Fridge-raiding Kim Jong-un ‘sparing no expense' to get hands on Ozempic – but he'll test on guinea pig civilians first
It comes as sources told how the North Korean tyrant's obesity-related health problems has forced a shift in his role as Supreme Leader.
7
7
7
Wary Kim has now ordered his close confidants to find new medicines abroad to help him trim back, such as Ozempic or a similar drug.
Insiders say fridge-raider Kim - who is known to have a legendary appetite - will likely bulk-buy a weight-loss drug before testing it on citizens with a similar figure.
One senior North Korea observer said: "If the past is any guide, it is probable that they'd make a bulk purchase.
"Because it's a new drug and a new drug to Kim, they might select North Korean citizens with a similar body type and medical history as Kim so they try the drug first for any side effects.
"Kim's father, Kim Jong Il, once had some of his aides injected with opiates.
"That way, if he became dependent or addicted, they'd all have to detox together."
Plump Kim, who stands at just 5ft 6ins, tipped the scales at a whopping 22 stone at his largest before shedding the pounds.
Eye-opening images revealed a drastic weight loss in 2021 - but the Supreme Leader has again ballooned to up to over 20 stone.
Kim's health has long raised eyebrows - and his love for cigarettes, drinking and imported cheese is a far cry from a healthy diet.
North Korea's 'Benidorm' to FINALLY open next week as tyrant Kim Jong-Un cuts ribbon - and Brits have signed up to visit
He is suspected to suffer from high blood pressure and diabetes, as well as gout - joint pain linked to a rich diet.
Both Kim's father and grandfather died from heart issues, making the dictator likely fearful of the same fate.
Michael Madden, founder of NK Leadership Watch, told The Sun: "When we see him in state media reporting, he is often sitting down.
"He doesn't walk any great distances, and he uses the car more often to travel short distances at public engagements.
"This also raises the question - what has caused the weight gain?
"Is it a combination of compulsive stress eating, a sedentary lifestyle and lack of physical activity? Is it a side effect of medication?
"If Kim is on medications, do they treat a chronic medical condition that might result in weight gain or metabolism issues?
"Then again, do Kim's doctors tell him the truth about his health or conceal a more serious problem?"
South Korean spies this month claimed Kim is on the hunt for new weight-loss medicines such as Ozempic from Western countries.
And his inner circle will be doing everything they can to get their hands on what their Dear Leader demands.
7
7
7
Mr Madden added: "When it comes to the leader's medical treatments, the regime spares no effort or expense to import the best available medicine, medical devices etc, from foreign countries, usually from Central Europe.
"If things get pretty dire, the North Koreans will retain foreign physicians and other specialists.
"The way this happens is through the Personal Secretariat, which is Kim's executive office as leader and runs his households and domestic life.
"The Personal Secretariat has what they call a 'network of correspondents'.
"These are elite North Koreans working either in small work teams or as individuals at North Korean embassies or other foreign missions.
"They perform a number of discreet tasks on behalf of Kim and some core elites - collecting or interpreting information, making purchases, conducting off the record interactions."
Top insiders noted "significant process changes in the regime" as Kim 's daughter Ju-ae takes on an "expanding" role - while the dumpy despot takes more of a backseat at events.
Kim has yet to anoint an official successor - though his daughter, believed to be 12 or 13, is touted as a strong possibility.
When it comes to the leader's medical treatments, the regime spares no effort or expense to import the best available medicine, medical devices etc, from foreign countries, usually from Central Europe
Michael Madden
One source said: "Restrictions on or disappearing of senior officials from public events is a sign of political transition or regime collapse; in North Korea, it's the former.
"The biggest things here are his inaccessibility at public events and the evolving public presence of Ju-ae.
"Kim used to be fairly easy to interact with at public events, now they hang back and don't engage as freely as before.
"Ju-ae's role and profile have expanded. In the last month, she has started wearing new, more mature clothing. She's starting to resemble her mum.
"Ju-ae is also interacting with foreign and DPRK leadership figures more readily."
Rumours have also swirled Kim's Gucci-loving daughter Ju-ae is on route to one day take the reins after she was seen accompanying her father at several missile launches.
She is regularly presented in carefully controlled state media as his "beloved" and "precious" child - fuelling rumours about her role in the regime in the future.
Kim's iron-fist sister Kim Yo-jong, wife Ri Sol ju, brother Kim Jong-chul, his top generals - premier Kim Tok-hun, general Choe Ryong-hae and marshal Pak Jong-chon could also be in the running.
A source added: "We are definitely seeing the outliers for succession.
"The 10th Party Congress in 2031 will likely be Ju-ae's major debut as a North Korean elite."
7
Kim's legendary appetite
INTELLIGENCE services and insiders have previously claimed Kim Jong-un is a prolific binge eater, drinker and smoker.
The Kim family's ex-sushi chef Kenji Fujimoto has claimed the dictator once boasted he had consumed ' 10 bottles of Bordeaux" during a meal.
Kim is also reportedly absolutely crackers about Emmental cheese after developing a taste for it while studying in Switzerland as a teen.
Cheese and wine are not the only treats Kim enjoys however, with only the best being good enough for the North Korean leader as his people starve and live in poverty.
Kim's staff reportedly brought along a host of high calorie and luxurious foods for their leader during his summit with US President Donald Trump in Vietnam in March 2019.
A team of personal chefs was also brought along to help tend to Kim - with the cook at Hanoi's luxury Metropole saying they tasted dishes for an hour to make sure they were perfect for their leader.
Cavier and lobster are both also reportedly part of Kim's palate, even though both are banned from being imported into North Korea by the United Nations.
Kim is also a fan of the delicacy shark fin soup, according to Mr Fujimoto.
Booze-loving Kim also reportedly likes to drink at least two bottles of Cristal Champagne per sitting, the chef said.
Bottles of the ritzy plonk can cost up to £7,500 - meaning Kim could drink away £15,000 during every meal.
Hundreds of thousands of bottle of cognac and vodka are also reportedly regularly imported to the Pyongyang, believed to be bound for Kim and the North Korea elite.
Kim is also reported to have pushed from a Western-style burger joint - such as a McDonald's - to open in North Korea during talks with the US.
Kim allegedly hated being called fat - being dubbed Kim Fatty III in Chinese media.
North Korea officials reportedly made a state request to China to get them to drop the nickname.
Other insulting names used by Kim's nearest ally include Kim Fat Fatty and Kim Abundant III.
Donald Trump even called Kim "short and fat" on Twitter as the two traded barbs before their string of high profile summits in 2018.
North Korea experts have previously claimed Kim's weight is actually a well-cultivated ploy to make him look like his revered grandfather Kim Il-sung.
His grandad is also claimed to have been a gourmand, having cows fed beer and had them massaged to make the meat more tender.
Kim's dad Kim Jong-il also died of a heart attack in 2011.
And while people may crack jokes about Kim's weight battle, around 40% of North Korea's population is undernourished.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
an hour ago
- The Independent
FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths
U.S. health regulators are warning doctors and patients about safety issues with two separate Boston Scientific heart devices recently linked to injuries and deaths. The Food and Drug Administration issued two alerts Wednesday about electrical problems tied to the company's heart-zapping defibrillator systems and a separate issue with a heart implant used to reduce stroke risk. The agency said the company's Endotak Reliance defibrillator wires can become calcified, leading to failures in delivering life-saving shocks to the heart, according to the FDA. Defibrillators are surgically placed in the upper chest, where they monitor irregular heartbeats and use electrical shocks to jolt the heart back to normal. As of July 24, Boston Scientific has reported 386 serious injuries and 16 deaths associated with this issue, the agency said. Ten of the deaths were judged to be due to the device failing to function properly, the company said in an email. Four were linked to attempts to surgically remove the devices from patients and two others were deemed unrelated to the implants. Boston Scientific's wires were distributed between 2002 and 2021 and are no longer available, the company noted in its letter to doctors. Some patients will need to have the devices replaced, though physicians should weigh the risks of the removal procedure. In a separate notice, the FDA said Boston Scientific recently updated instructions for implanting its Watchman device, which closes a portion of the heart's left atrium to reduce the risk of stroke. In a letter to physicians, the company noted that there is an increased risk of blockages in the bloodstream depending on the level of anesthesia for patients undergoing the initial implantation procedure. Watchman is an alternative to long-term treatment with blood thinners for patients at increased risk of stroke. As of July 30, the company has reported 120 serious injuries and 17 deaths related to the issue, the FDA said. A company investigation concluded that the safety issue 'is not associated with the design or manufacture of any component of the Watchman system. Heart devices, including defibrillators and other implants, are Boston Scientific's largest business, making up two-thirds of its $5 billion in revenue for the most recent quarter. Shares of Boston Scientific Corp. fell nearly 1.8 percent Wednesday to close at $102.95 in trading. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
Medical News Today
2 hours ago
- Medical News Today
Muscle loss from GLP-1 drugs like Ozempic may not be as high as thought
While past studies show that adults taking a GLP-1 medication can lose between 5-15% of their starting body weight, other research reports that a good portion of that weight loss comes from muscle loss. A new study says, via a mouse model, that muscle loss from GLP-1 medications like Ozempic may not be as high as recently thought. Researchers also found that the decrease in lean muscle mass was not all from skeletal muscles, but from other body tissues, including the polls estimate that one in every eight adults in the U.S. have taken a glucagon-like peptide-1 receptor agonist (GLP-1) — a class of prescription drugs originally used to treat type 2 diabetes that has gained popularity as a method of weight of GLP-1 medications include semaglutide, sold under the brand names Ozempic and Wegovy, and tirzepatide, sold under the brand names Zepbound and Mounjaro. Past studies show that adults taking a GLP-1 medication can lose between 5-15% of their starting body weight within one year. However, other research reports that about 25-39% of that weight loss is from muscle loss. Now, a new study recently published in the journal Cell Metabolism says, via a mouse model, that muscle loss from GLP-1 medications like Ozempic may not be as high as recently thought. Researchers also found that the decrease in lean muscle mass was not all from skeletal muscles, but from other body tissues, including the liver. Lean muscle mass loss not just from skeletal musclesFor this study, researchers used a mouse model to determine how GLP-1 medications like Ozempic affected lean muscle mass. Upon analysis, researchers found that Ozempic-related weight loss in mice resulted in a lean muscle mass decrease of about 10%, which is less than some previous studies report that as the mice lost weight, some skeletal muscles did decrease, while other muscles stayed the same. Researchers state that the muscle mass decrease is a return to baseline, as gaining fat is usually accompanied by a gain in skeletal muscle. Researchers found some mice experienced a decrease in strength in skeletal muscles that stayed almost the same researchers found that a good portion of the decrease in lean muscle mass did not come from skeletal muscles, but rather other tissues in the body, such as the liver, which they report reduced in size by almost half. It is not uncommon for the liver to decrease in size during weight loss, which can help reduce a person's risk for fatty liver disease.'If we want to really help the individuals who may be losing muscle mass, then we need to know that they're actually losing muscle mass,' Katsu Funai, PhD, associate professor of nutrition and integrative physiology in the University of Utah College of Health and the senior author on the study says in a press release. 'We have data in mice that suggest that things are not as straightforward as they might seem.'Working with a dietitian while taking GLP-1sMedical News Today spoke with Seth Kipnis, MD, FACS, FASMBS, director of bariatric and robotic surgery at Hackensack Meridian Jersey Shore University Medical Center in New Jersey, about this study, who commented that a drop in lean muscle mass is expected. Some muscle loss is inevitable'Any patient with a restricted diet and poor nutrition/protein will have a drop in muscle mass. The key of any weight loss program, surgical, medical or GLP-1 is adequate nutrition. Working with a registered dietitian is key to long-term success and avoiding complications of malnutrition.' — Seth Kipnis, MD, FACS, FASMBS'More and more people are taking these medications on a regular basis,' he continued. 'They are working well to control weight. We should know the side effects that can be caused in the long term so that patients can be counseled on how to avoid long-term issues.' Kipnis said he would like to see better long-term data as the next steps in this research. 'And are different outcomes found depending on the prescriber and the type of follow-up,' he added. 'It is our assumption that specialists in weight management and nutrition will have better outcomes than a primary care doctor that treats every disease. Obesity is a unique disease that requires specialists to manage.'Human trials needed to further analyze GLP-1s and muscle lossMNT also talked to Kais Rona, MD, a bariatric surgeon of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA.'As a physician who has treated and continues to treat many patients with GLP-1 medications such as Ozempic, I found this study quite interesting,' Rona said. 'Although the data in this study cannot be extrapolated directly to humans, it does shed some light on potentially important physiologic effects of the medication.' 'The decrease in lean mass with GLP-1 use was associated with a lesser decrease in skeletal muscle mass and a greater decrease in the size of metabolically active organs such as the liver. This can have important physiologic effects on metabolism and overall health. We also see a decrease in liver mass in patients undergoing weight loss surgery, which often leads to beneficial health effects. Importantly, this study also highlights the importance of determining the functional impact of muscle loss and whether that is reflected in a loss of strength as well.'— Kais Rona, MD'It's extremely important to continue to study the potential side effects, including the loss of lean muscle mass, associated with GLP-1 medications as it can have major effects on our healthcare system as a whole,' Rona added. 'Furthermore, we need to continue to broaden our understanding of the physiologic effects of these medications to optimize patient safety and overall outcomes.' Rona said the next best research step would be to perform randomized-controlled trials in humans to further analyze the effects of GLP-1 medications on lean mass as well as skeletal muscle mass. 'It would be important to evaluate its effects on muscle strength as well as function,' he added. 'Also to determine whether certain areas of the body are more susceptible to muscle loss as well as identifying preventive strategies to combat muscle loss.'
The Guardian
2 hours ago
- The Guardian
Depression, suicides, overdoses: broad impacts of US wildfires revealed in study
New research looking at the aftermath of some of the deadliest wildfires to have struck the US in recent years has shed light on the devastating effects the disasters have on human health, with impacts that extend far beyond the official death toll and injury counts. Three studies published this week examine the long-term fallout from the Maui and Los Angeles wildfires, including depression, suicide and overdose deaths, lung damage, and deaths caused by healthcare disruptions. The August 2023 Hawaii blazes killed more than 100 people, in what was the deadliest US wildfire in more than a century, and destroyed the town of Lahaina. The fires that tore through the LA communities of Altadena and the Pacific Palisades earlier this year killed 31 people and destroyed more than 18,000 structures. Some of the new research found that the Maui fire left one in five people with lung damage, and as many as half with symptoms of depression. That study, co-led by Ruben Juarez of the University of Hawaii, looked at more than 1,100 adults six to 14 months after the Maui fire. It found lower lung function in people in areas close to the fire compared with those in lower-exposure areas, with about 22% experiencing below-normal lung function. Additionally, about 40% of people reported their health had declined since the fires, according to the study, and close to half mentioned increased fatigue and weakness, eye irritation and lung-related symptoms. 'It's a stark reminder that wildfires can leave an invisible but lasting scar on respiratory health, long after the flames are gone,' Juarez told the Associated Press in an email. During the month of the fire, 13 suicides were reported in the area, nearly double the normal suicide and overdose death rates, another study found. The study of the Los Angeles fires, led by researchers in Finland, concluded that in addition to at least 30 deaths attributed to the fire, more than 400 deaths between January and February could be blamed on the event because of interruptions in healthcare and other factors. Dr Jonathan Patz, a University of Wisconsin environmental public health researcher who was not involved with the research, said the studies add 'a really important piece to the understanding of the true health risks from these extreme climatic events'. As the climate crisis fuels worsening disasters across the US, from flooding to deadly wildfires, scientists are trying to gain a better understanding of the impacts of extreme weather events. Research into the effects of wildfire smoke has surged in recent years as massive blazes have caused orange skies and unhealthy air for millions of people from the west coast to New York. A 2021 study found that breathing wildfire smoke during pregnancy raises the risk of premature birth. Research published earlier this year found the climate crisis contributed to about 15,000 deaths from exposure to small particulate matter from wildfires and cost about $160bn between 2006 and 2020. Another study, published in 2024, determined that wildfire smoke prematurely killed more than 50,000 people in California over a decade. Kristie Ebi of the University of Washington noted that there is a growing understanding that wildfire smoke can be more toxic than standard air pollution. 'It's not just leaves and branches and trees' that are burned, she said. 'It's buildings. It's gasoline stations. It's old houses that have asbestos in them. It's automobiles. There are lots of components of wildfire smoke.' She said the study of the Maui fire suggests 'this toxicity is affecting people's long-term lung function', but noted more research is needed to look at cause and effect. Meanwhile, the research calculating rates of suicide and overdose deaths in Maui and Hawaii's four other counties found a 97% increase in both on Maui during the month of the wildfires. The total number of suicide and overdose deaths was 13 that month, most of them suicides. That's a significant increase, Ebi said. They also found a 46% increase in such deaths in all five counties, which may have been influenced by displaced Maui residents migrating to other islands, the authors said. But rates fell in the following months. In addition to the studies published this week, a new report from the University of Hawaiʻi Economic Research Organization (UHERO), which is based on nearly a year of data from surveys of 950 people, documented the challenges that persist for those affected by the Maui fire. Two years later, some have found permanent housing and greater economic stability, but many people are still displaced and have faced long-term income loss and high rent burdens. While permanent housing is increasing, poverty rates in the region have almost doubled as full-time employment has not yet fully returned to pre-fire levels and nearly 60% of households report lower income. 'Our findings show two realities unfolding side by side,' said Daniela Bond-Smith, a UHERO research economist. 'Some households are finding new footing – moving into stable housing, returning to work and regaining stability. But others are still living with deep uncertainty, especially those with limited support and population groups who had already been marginalized prior to the fires.'
